Section archive

PSA

Drug

Prostate cancer screening no benefits for men with low PSA value

For men aged 55 to 74 with PSA levels below 2 ng/mL, 24,642 would need screening and 724 prostate cancers would need treating to prevent one death, an analysis of more than 86,000 men found. For men with levels between 10 and 19.9 ng/mL, 133 screenings would prevent one death.

Healthcare

Too many men get aggressive treatment for prostate cancer - study

An Archives of Internal Medicine study of men diagnosed with prostate cancer between 2004 and 2006 found those with PSA under 4 were treated much like men with levels of 4 to 20. More than 70 percent of men below 20 ng/mL had their prostates removed or underwent radiation.

Jul 28, 2010

Cancer

Swedish Study: PSA Screening Saves Lives

A University of Gothenburg study followed 20,000 men for 14 years and found prostate cancer deaths were half as high among those offered PSA screening. Critics point to overdiagnosis: one US study found that for every 20 men treated, only one benefits from early screening.

Jul 1, 2010

Drug

Too many elderly men receive PSA testing - study

Among 9,000 U.S. men aged 76 or older with no prostate cancer history, 60 percent reported a PSA test in the past year, despite 2008 task force guidance against screening men 75 and older.

Jun 21, 2010

4 stories